Abbott Laboratories
ABT
$107.39
Share price
0.50%
Change (1 day)
-2.35%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Abbott Laboratories (ABT) - Net assets
Net assets on the balance sheet as of December 2023 : $38.82 B
According to Abbott Laboratories's latest financial reports the company has $38.82 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Abbott Laboratories - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $38.82 B | 5.21% |
| 2022-12-31 | $36.90 B | 2.45% |
| 2021-12-31 | $36.02 B | 9.15% |
| 2020-12-31 | $33.00 B | 5.44% |
| 2019-12-31 | $31.30 B | 1.88% |
| 2018-12-31 | $30.72 B | -1.21% |
| 2017-12-31 | $31.09 B | 50.11% |
| 2016-12-31 | $20.71 B | -2.86% |
| 2015-12-31 | $21.32 B | -1.45% |
| 2014-12-31 | $21.63 B | -14.36% |
| 2013-12-31 | $25.26 B | -5.77% |
| 2012-12-31 | $26.81 B | 9.32% |
| 2011-12-31 | $24.52 B | 7.74% |
| 2010-12-31 | $22.76 B | -0.58% |
| 2009-12-31 | $22.89 B | 30.71% |
| 2008-12-31 | $17.51 B | -1.46% |
| 2007-12-31 | $17.77 B | 26.5% |
| 2006-12-31 | $14.05 B | -2.5% |
| 2005-12-31 | $14.41 B | 0.62% |
| 2004-12-31 | $14.32 B | 9.59% |
| 2003-12-31 | $13.07 B | 22.58% |
| 2002-12-31 | $10.66 B | 17.72% |
| 2001-12-31 | $9.05 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | 77.13% | 🇺🇸 USA |
 Novartis NVS | $46.75 B | 20.41% | 🇨🇭 Switzerland |
 Pfizer PFE | $89.28 B | 129.96% | 🇺🇸 USA |
 Medtronic MDT | $51.99 B | 33.92% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | $46.84 B | 20.64% | 🇺🇸 USA |
 Boston Scientific BSX | $19.53 B | -49.70% | 🇺🇸 USA |
 Hologic HOLX | $4.65 B | -88.01% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $29.48 B | -24.06% | 🇺🇸 USA |
 AstraZeneca AZN | $39.16 B | 0.87% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $16.28 B | -58.05% | 🇬🇧 UK |